Exosomal profile change during Durvalumab treatment
Not Applicable
- Conditions
- on-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000042280
- Lead Sponsor
- The Jikei University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 231
Inclusion Criteria
Not provided
Exclusion Criteria
Exclude NSCLC patients with other types of cancer.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method